Sanofi ADR (SNY)

  • A brief financial summary of Sanofi ADR as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
SNY NASDAQ USD Real-time SANp BATS Europe EUR Delayed 0O59 London EUR Real-time SNYN Mexico MXN Delayed SANF Milan EUR Real-time SASY Xetra EUR Delayed SASY Frankfurt EUR Delayed SASY TradeGate EUR Delayed SASY Paris EUR Real-time SASY Vienna EUR Real-time
54.28 -0.92 (-1.67%)
Closed USD Disclaimer
54.19 -0.09 (-0.17%)

SNY Financial Summary

Sanofi reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was EUR 9,965 million compared to EUR 10,116 million a year ago. Net income was EUR 1,435 million compared to EUR 1,175 million a year ago. Basic earnings per share from continuing operations was EUR 1.15 compared to EUR 0.94 a year ago.For the six months, sales was EUR 20,187 million compared to EUR 19,790 million a year ago. Net income was EUR 3,430 million compared to EUR 3,184 million a year ago. Basic earnings per share from continuing operations was EUR 2.74 compared to EUR 2.55 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
SNY Income Statement
SNY
Gross margin TTM 69.8%
Operating margin TTM 23.87%
Net Profit margin TTM 18.71%
Return on Investment TTM 10.25%
Total Revenue
Net Income
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Total Revenue 10,588 10,863 11,456 13,138
Gross Profit 7,325 7,784 7,725 9,307
Operating Income 1,546 2,821 1,661 4,652
Net Income 1,435 1,995 3,111 2,076

Customize

Clear All
0Selected
Please try another search
SNY Balance Sheet
SNY
Quick Ratio MRQ 0.66
Current Ratio MRQ 1.22
LT Debt to Equity MRQ 19.61%
Total Debt to Equity MRQ 28.95%
Total Assets
Total Liabilities
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Total Assets 125,353 126,722
Total Liabilities 52,406 51,570
Total Equity 72,947 75,152 75,152 71,304

Customize

Clear All
0Selected
Please try another search
SNY Cash Flow Statement
SNY
Cash Flow/Share TTM 8.21
Revenue/Share TTM 36.83
Operating Cash Flow 0.00%
Cash
Net Change in Cash
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash

Customize

Clear All
0Selected
Please try another search

* In Millions of EUR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.